Akero Therapeutics, Inc. reports

Company location: South San Francisco, CA
Fiscal year end: 31 December

Akero Therapeutics, Inc. has filed 734 SEC EDGAR filings since 18 Dec 2018

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 451-475 of 734 matching filings.

Per page

25

Current page

19

4

FORM 4 SUBMISSION

Filing date: 15 Sep 2022
Reporting date: 13 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Sep 2022
Reporting date: 13 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Sep 2022
Reporting date: 13 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Sep 2022
Reporting date: 13 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-256229

424B5

Filing date: 15 Sep 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-91047

SC 13D/A

Filing date: 15 Sep 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 13 Sep 2022
Reporting date: 09 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 13 Sep 2022
Reporting date: 09 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 13 Sep 2022
Reporting date: 09 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 13 Sep 2022
Reporting date: 09 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 13 Sep 2022
Reporting date: 09 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-256229

424B5

Filing date: 13 Sep 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38944

8-K

Filing date: 13 Sep 2022
Reporting date: 13 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-38944

10-Q

Filing date: 05 Aug 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38944

8-K

Filing date: 04 Aug 2022
Reporting date: 04 Aug 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G File 005-91047

SC 13G AKERO THERAPEUTICS

Filing date: 28 Jun 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38944

8-K

Filing date: 16 Jun 2022
Reporting date: 15 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

424B5 File 333-256229

424B5

Filing date: 16 Jun 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38944

8-K

Filing date: 08 Jun 2022
Reporting date: 08 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Jun 2022
Reporting date: 02 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Jun 2022
Reporting date: 02 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Jun 2022
Reporting date: 02 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Jun 2022
Reporting date: 02 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Jun 2022
Reporting date: 02 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38944

8-K

Filing date: 03 Jun 2022
Reporting date: 02 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .